MDAI · Spectral AI, Inc. · Earnings Call Transcripts & Audio
Market Cap
$51.50M
Shares
32.18M
Spectral AI, Inc. Earnings Call Transcripts
Quarterly earnings calls for Spectral AI, Inc. (MDAI), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼51.1%
$3.44M
−$10.63M
'23 Q3
23-11-14
·
$5.29M
−$3.55M
'23 Q4
24-03-29
▲24.6%
$6.33M
−$3.21M
'24 Q1
24-03-31
▲75.9%
$7.48M
−$2.86M
'24 Q2
24-06-30
▲137.6%
$8.17M
−$1.50M
'24 Q3
24-09-30
▲6%
$6.71M
$2.90M
'25 Q1
25-05-14
▼32.3%
$5.07M
−$7.97M
'25 Q2
25-08-13
▼53.6%
$3.79M
−$3.55M
'25 Q3
25-09-30
▼46.3%
$4.09M
$1.05M
'25 Q4
26-03-25
LATEST
▼30.4%
$3.52M
−$4.18M
'26 Q2
26-08-12
Earnings call
FY26 · Q2
2026-08-12
Spectral AI, Inc. (MDAI) Q2 2026 Earnings Call
Revenue
$3.52M
▼ 30.4% YoY Diluted EPS
$-0.13
Gross margin
31.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-25
Spectral AI, Inc. (MDAI) Q4 2025 Earnings Call Transcript
Confident tone
BARDA Contract and Funding
DeepView System Commercialization
FDA De Novo Submission and Approval
Revenue
$4.09M*
▼ 46.3% YoY Gross margin
45.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Spectral AI, Inc. (MDAI) Q3 2025 Earnings Call Transcript
Positive tone
BARDA Project BioShield contract
DeepView system commercialization
Handheld device and military applications
Revenue
$3.79M
▼ 53.6% YoY Diluted EPS
$-0.13
Gross margin
42.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Spectral AI, Inc. (MDAI) Q2 2025 Earnings Call Transcript
Positive tone
FDA submission / DeepView de novo clearance
Handheld / Snapshot device
Revenue and financial performance
Revenue
$5.07M
▼ 32.3% YoY Diluted EPS
$-0.31
Gross margin
45.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Spectral AI, Inc. (MDAI) Q1 2025 Earnings Call Transcript
Confident tone
Burn Validation Study
FDA De Novo Submission
BARDA Project BioShield Contract
Revenue
$6.71M
▲ 6% YoY Diluted EPS
$0.11
Gross margin
47.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-09-30
Spectral AI, Inc. (MDAI) Q3 2024 Earnings Call Transcript
Confident tone
Leadership Renewal and 3 Fs Framework
UK and Australia International Expansion
BARDA Contract and Government Funding
Revenue
$8.17M
▲ 137.6% YoY Diluted EPS
$-0.08
Gross margin
44.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Spectral AI, Inc. (MDAI) Q2 2024 Earnings Call Transcript
Confident tone
Commercialization of DeepView in the UK
Pivotal study enrollment
Geographic expansion and partnerships
Revenue
$7.48M
▲ 75.9% YoY Diluted EPS
$-0.16
Gross margin
44.3%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Spectral AI, Inc. (MDAI) Q1 2024 Earnings Call Transcript
Confident tone
BARDA Project BioShield contract
Clinical studies (burn pivotal and DFU)
Spectral IP subsidiary / spin-off
Revenue
$6.33M
▲ 24.6% YoY Diluted EPS
$-0.19
Gross margin
46.6%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-29
Spectral AI, Inc. (MDAI) Q4 2023 Earnings Call Transcript
Confident tone
DeepView Burn Indication Commercialization
U.S. Government / BARDA Contract (Project BioShield)
2024 Financial Outlook / Revenue Guidance
Revenue
$5.29M*
Gross margin
46.1%
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-14
Spectral AI, Inc. (MDAI) Q3 2023 Earnings Call Transcript
Revenue
$3.44M
▼ 51.1% YoY Diluted EPS
$-0.77
Gross margin
42.8%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Showing 1–10 of 10 earnings calls